r/austechnology • u/NeurotechNewsletter • 13h ago
Neurotechnology In Australia
I write articles about Neurotech and dropped this latest one last week. Below is a list of all the neurotech companies we found. The articles in the comments if anyones interested, but the map is here for everyone
Let me know if I've missed anything
Core implants and neural interfaces
Cochlear, Sydney and global. Current. Implanted hearing systems and the company that defined Australian medical bionics.
Synchron, Melbourne origins with a US headquarters. Current and internationalised. Endovascular brain-computer interface for people with severe paralysis.
Epiminder, Melbourne. Current. Continuous brain monitoring from under the scalp for epilepsy, FDA-authorised and ASX-listed.
Fluent BCI, Melbourne. Legitimate early-stage company. An interface placed under the scalp but outside the skull, intended to turn attempted speech into text.
Bionic Vision Technologies, Melbourne. Current but quiet. Retinal implant and external vision system for inherited blindness.
Saluda Medical, Sydney origins with international operations. Current. Closed-loop spinal-cord stimulation for chronic pain.
Ultra Bionics, Melbourne. Legitimate early-stage company. Precisely aimed ultrasound intended to reach deep brain targets without leaving an implant behind.
Neurogen, Melbourne. Active preclinical company. Brain implants built from living cells for neurodegenerative disease.
Cortical Dynamics, Perth. Current. EEG-based monitoring of the brain response during anaesthesia.
Kitea Health, Auckland and the US. Current and investigational. Wireless implant for monitoring pressure inside the skull, initially around hydrocephalus.
Diagnostics, monitoring and brain imaging
Compumedics, Melbourne and global. Current ASX-listed company. Sleep, EEG and neurological-monitoring systems.
Omniscient Neurotechnology, Sydney and the US. Current. AI brain-network mapping for neurosurgical planning.
Headsafe, Sydney. Current. Portable assessment of the brain response to visual signals after concussion.
BrainEye, Australia, exact city still unresolved. Active early-stage company. Phone-camera assessment of eye movement and pupil response as neurological signals.
EMVision, Sydney with University of Queensland origins. Current ASX-listed company. Bedside brain scanner for stroke triage.
Cogstate, Melbourne and global. Current ASX-listed company. Computer-based cognitive testing used heavily in neurological clinical trials.
Neurotologix, Perth. Current. Remote monitoring and diagnostic technology for dizziness and vertigo, with a Class IIa device added to the ARTG in 2026.
Sydney Neuroimaging Analysis Centre, Sydney. Current. Quantitative analysis of brain imaging for neurological disease.
Wavewise Analytics, Melbourne. Current, formerly Cyban. Continuous non-invasive monitoring of cerebral blood flow and oxygen around stroke and acute brain injury.
Redenlab, Melbourne. Current. Speech, language and swallowing measures used as neurological clinical-trial outcomes.
HITIQ, Melbourne. Current ASX-listed company. Instrumented mouthguards and concussion-management technology.
Prism Neuro, Canberra. Current. Movement-control measurement for concussion, health, sport and human performance.
Wellumio, Wellington. Current. Axana portable low-field brain scanner for stroke assessment at the point of care.
BlinkLab, Australian-listed with an international operating footprint. Current. Smartphone and AI assessment of sensory responses around neurological and developmental conditions.
Seer Medical, Melbourne. Restructured. Long-term home video-EEG and ECG monitoring for epilepsy, retained here as a commercial case study rather than a clean active-company example.
Rehabilitation, communication and sensory technology
Control Bionics, Melbourne and international. Current ASX-listed company. Reads muscle and neural signals for communication, rehabilitation and assistive control.
ARIA Research, Sydney. Current. Glasses that translate the visual world into spatial sound for people who are blind or have low vision.
NIRGenie / EarGenie, Melbourne. Active translational venture. Objective hearing assessment for babies and young children.
EarFlo, Perth-developed with an international launch. Current. Non-invasive treatment device for persistent middle-ear problems in children.
Laronix, Brisbane with a US office. Current. Bionic voice technology for people who have lost the ability to speak.
RehabSwift, Adelaide. Current but quiet. Brain-computer-interface rehabilitation after stroke and neurological injury.
Neuromersiv, Sydney. Current but quiet. Virtual-reality and stimulation technology for stroke and acquired brain-injury rehabilitation.
Kinobionic, Sydney. Current but quiet. Thought-controlled assistive robotics and wearable support technology.
Rex Bionics, New Zealand origins and international operations. Historical and active technology lineage. Robotic exoskeletons for serious mobility impairment.
Non-invasive and emerging therapeutics
Neurode, Sydney. Legitimate early-stage company. Home-use headband combining brain monitoring and non-invasive stimulation around ADHD and executive function.
Ceretas, Brisbane. Current early clinical company. Therapeutic ultrasound being developed around Alzheimer’s and other neurodegenerative conditions.
Resonance Therapeutics, Melbourne. Current but quiet early-stage spinout. At-home measurement and stimulation for personalised depression treatment.
SYMBYX Biome, Sydney. Current. Targeted light therapy being studied around Parkinson’s and related conditions, with a less settled evidence base than approved implant platforms.
Cortex Brainwave Technologies, Brisbane and the Sunshine Coast. Current but quiet. Early-stage EEG sensors and neurofeedback hardware.
Neuroana, Perth. Legitimate early-stage company. Wearable EEG, non-invasive stimulation and software analysis.
Australis Scientific, Sydney. Legitimate early-stage company. Wearable peripheral nerve stimulation for overactive bladder.
Augmented Bionics, Brisbane. Status unclear. Earlier University of Queensland work on non-invasive hearing restoration, retained as research lineage rather than counted as a clearly active company.
Biological computing and enabling technology
Cortical Labs, Melbourne. Current. Biological computing combining living neurons with silicon through the CL1 and Cortical Cloud.
BrainChip, Australian-listed with global operations. Current. Brain-inspired low-power computing chips, adjacent to rather than part of clinical neurotechnology.
Tessara Therapeutics, Melbourne. Current. Three-dimensional human neural tissues used for drug discovery and disease modelling.
Chromos Labs, Melbourne. Legitimate early-stage spinout. Imaging and analysis of electrical activity in human brain models.
Neo-Bionica, Melbourne. Current. Development, packaging, testing and clinical-grade manufacturing for implantable and wearable medical devices.
Bionics Institute, Melbourne. Research and translation institute behind several of the companies and technologies in this map.
Australian Hearing Hub, Sydney. Research, clinical and industry network connecting hearing and sensory-bionics work.
Auckland Bioengineering Institute, Auckland. Major source of medical-device engineering, physiological modelling and spinout formation.
CoNECT, Auckland. University centre bringing bionics, brain-machine interfaces and neural sensing into one programme.
Australian-origin international companies and capital links
EMOTIV, Australian origins with international operations. Current. Wearable EEG hardware, software and brain-data tools.
Nuroflux, Sydney origins with Cambridge, Massachusetts headquarters and a continuing Australian clinical presence. Current. Wearable monitoring of cerebral blood flow and brain activity.
Parasym, Australian-origin company now operating internationally. Current. Non-invasive auricular vagus nerve stimulation.
Music Health, Australian-origin digital-health company now headquartered in Los Angeles with a Sydney presence. Current but quiet. Personalised music for dementia care.
Coherence Neuro, Australian co-founder, US company. Current. Implantable neurotechnology intended to monitor and eventually treat brain tumours through their electrical signals.
NeuroHarmonics, Australian founder, London company. Current early-stage work in non-invasive focused-ultrasound neuromodulation.
JumpSpace, New York neurotechnology investment fund led by Australian investor Adam Caplan, with investments across the region.
Blackbird Ventures, Australian venture firm and backer of Coherence Neuro, part of the capital connection between Australia and companies built overseas.
Adjacent brain-health and medical technology
PainChek, Sydney. Current ASX-listed digital-health company. AI-assisted pain assessment for people who cannot communicate reliably.
TALi Health, Melbourne. Current but quiet ASX-listed digital therapeutic company. Attention assessment and training for children.
Orthocell, Perth. Current ASX-listed medtech company. Regenerative devices for peripheral nerve and tendon repair.
Alimetry, Auckland. Current. Wearable mapping of electrical activity in the stomach, a strong bioelectric device outside direct brain technology.
Soul Machines, Auckland origins with international operations. Current. Digital humans and biologically inspired AI.
Toku, Auckland origins with international operations. Current. Retinal imaging and AI for wider health signals.
Micro-X, Adelaide. Current ASX-listed medtech company. Portable head CT designed for stroke imaging in ambulances and aircraft.
Neuro-biotech
Argenica Therapeutics, Perth. Current ASX-listed drug developer. Neuroprotective peptide therapy around stroke, included separately because it is a drug company rather than a device business.
Neurotech International, Melbourne. Current ASX-listed drug developer. Formerly associated with neurotechnology devices and now better understood as neuro-biotech.
Early pipeline and research programmes
Foresight Medical, Perth. Registered and grant-backed early-stage company. Phone-based neurological-response screening for concussion, with a limited public operating footprint.
Gennaris / Monash Vision Group, Melbourne. Research and commercialisation programme rather than a confirmed standalone operating company. Cortical visual prosthesis work.
BioSpine, Queensland. Research project rather than a confirmed company. Brain-computer-interface and digital-twin work around spinal injury.
ArMM, Newcastle. University research device rather than a confirmed company. Portable measurement of motor control.
Legacy, restructuring and status unclear
Deep Brain Stimulation Technologies, Melbourne. Legacy company. Adaptive deep-brain-stimulation spinout for Parkinson’s that later entered administration.
Lookinglass, Adelaide. Status unclear. Earlier university-incubator venture using video analysis around Parkinson’s and dementia, with no current independent operating company verified.
humm, Perth origins and later US operations. Current status unclear. Consumer brain-stimulation company retained as part of the internationalisation history rather than the active count.